rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert E. Abernathy

Director

Company insider

Files Form 4 as: Director, Avient; Director, Haemonetics; President and CEO, Avanos Medical; Executive Vice President, Kimberly-Clark; Director, Radioshack; Director, Lubrizol.

Every Form 4 they filed

In numbers

Trades disclosed
241
Buys
6
Sells
20
Bought
$1.4M
Sold
$65.4M
Companies
6
Companies where not an officer
4
First trade
2 Feb 2006
Last trade
30 Sep 2026
Last filed
2 Oct 2026

Companies traded

Where they are an officer
Avanos MedicalDirector, Officer · Medical Devices · last 3 May 20171 buy · 0 sells
KMB Kimberly-ClarkOfficer · Household & Personal Care · last 19 Jun 20140 buys · 20 sells
Everywhere else they filed: board seats, 10% stakes, other companies
AVNT AvientDirector · Chemicals · last 30 Sep 20261 buy · 0 sells
HAE HaemoneticsDirector · Medical Devices · last 24 Jul 20261 buy · 0 sells
RadioshackDirector · last 2 Jun 20143 buys · 0 sells
LubrizolDirector · last 16 Sep 20110 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month. 1 lines have no legible date and are left out.

Every trade

TradedCompanyWhatAmount
30 Sep 2026filed 2 Oct 2026AVNT AvientChemicalsSEC FORM 4 Code A—958 at $0.00filing
24 Jul 2026filed 28 Jul 2026HAE HaemoneticsMedical DevicesSEC FORM 4 Code A—2,538filing
24 Jul 2026filed 28 Jul 2026HAE HaemoneticsMedical DevicesSEC FORM 4 Code A—2,538filing
30 Jun 2026filed 2 Jul 2026AVNT AvientChemicalsSEC FORM 4 Code A—1,049 at $0.00filing
30 Jun 2026filed 2 Jul 2026AVNT AvientChemicalsSEC FORM 4 Code A—1,049 at $0.00filing
31 Mar 2026filed 2 Apr 2026AVNT AvientChemicalsSEC FORM 4 Code A—1,072 at $0.00filing
31 Mar 2026filed 2 Apr 2026AVNT AvientChemicalsSEC FORM 4 Code A—1,072 at $0.00filing
31 Dec 2025filed 5 Jan 2026AVNT AvientChemicalsSEC FORM 4 Code A—1,239 at $0.00filing
31 Dec 2025filed 5 Jan 2026AVNT AvientChemicalsSEC FORM 4 Code A—1,239 at $0.00filing
30 Sep 2025filed 2 Oct 2025AVNT AvientChemicalsSEC FORM 4 Code A—1,192 at $0.00filing
24 Jul 2025filed 25 Jul 2025HAE HaemoneticsMedical DevicesSEC FORM 4 Code A—2,693filing
30 Jun 2025filed 2 Jul 2025AVNT AvientChemicalsSEC FORM 4 Code A—1,187 at $0.00filing
31 Mar 2025filed 2 Apr 2025AVNT AvientChemicalsSEC FORM 4 Code A—1,055 at $0.00filing
31 Dec 2024filed 3 Jan 2025AVNT AvientChemicalsSEC FORM 4 Code A—955 at $0.00filing
30 Sep 2024filed 2 Oct 2024AVNT AvientChemicalsSEC FORM 4 Code A—775 at $0.00filing
25 Jul 2024filed 26 Jul 2024HAE HaemoneticsMedical DevicesSEC FORM 4 Code A—2,207filing
28 Jun 2024filed 1 Jul 2024AVNT AvientChemicalsSEC FORM 4 Code A—806 at $0.00filing
29 Mar 2024filed 1 Apr 2024AVNT AvientChemicalsSEC FORM 4 Code A—808 at $0.00filing
29 Dec 2023filed 3 Jan 2024AVNT AvientChemicalsSEC FORM 4 Code A—834 at $0.00filing
29 Sep 2023filed 3 Oct 2023AVNT AvientChemicalsSEC FORM 4 Code A—984 at $0.00filing

Sectors

Consumer Staples20
Health Care2
Materials1
Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Patricia CorsiChief Growth Officer · Chief Growth Officer at Kimberly Clark, filing Form 4 there in the last year
Craig SlavtcheffChief R&D Officer · Chief R&D Officer at Kimberly Clark, filing Form 4 there in the last year
Indrani Lall FranchiniDirector · Director at Avanos Medical, filing Form 4 there in the last year
Patrick J. OlearyDirector · Director at Avanos Medical, filing Form 4 there in the last year
Julie Ann ShimerDirector · Director at Avanos Medical, filing Form 4 there in the last year
Donald J. TrumpPresident · Also traded KMB in the last 90 days
Kevin HernRepresentative, OK-01 · Also traded KMB in the last 90 days